Literature DB >> 2786843

Antibody to the outer membrane proteins is the dominant opsonic antibody in normal human serum against H. influenzae type b.

S V Hetherington1.   

Abstract

We hypothesized that the predominant opsonic antibody of normal serum is directed against outer membrane proteins (OMP). Sera from 10 normal adults were tested for their opsonic capacity against Haemophilus influenzae b (Eagan strain) by the luminol-enhanced neutrophil chemiluminescence elicited on incubation with serum-opsonized bacteria, and the ability to deposit C3 on the bacterial surface. Peak chemiluminescence correlated with the amount of C3 on the bacterial surface (r = 0.71, P less than 0.025) and this, in turn, correlated with the concentration of IgG directed against outer membrane proteins, (r = 0.75, P less than 0.01), but not with the concentration of anticapsular polysaccharide antibody. Two groups of sera were easily distinguished based on the chemiluminescence experiments: a high opsonic group (greater than 50,000 peak counts per second; c.p.s.) and a low opsonic group (less than 10,000 c.p.s.). The IgG fraction from the high opsonic sera could augment C3 deposition when added to a low opsonic serum, but could not after absorption of the anti-OMP antibody by affinity chromatography. We conclude that the predominant opsonin of normal serum is antibody to outer membrane proteins, a finding which could be significant for the development of future vaccines against H. influenzae b.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2786843      PMCID: PMC1385293     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  23 in total

1.  Participation of complement in the nonimmune host defense against experimental Haemophilus influenzae type b septicemia and meningitis.

Authors:  F J Crosson; J A Winkelstein; E R Moxon
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

2.  Opsonic requirements for staphylococcal phagocytosis. Heterogeneity among strains.

Authors:  J Verhoef; P Peterson; Y Kim; L D Sabath; P G Quie
Journal:  Immunology       Date:  1977-08       Impact factor: 7.397

3.  A simplified method for cyanogen bromide activation of agarose for affinity chromatography.

Authors:  S C March; I Parikh; P Cuatrecasas
Journal:  Anal Biochem       Date:  1974-07       Impact factor: 3.365

4.  Experimental Haemophilus influenzae type b meningitis: immunological investigation of the infant rat model.

Authors:  D M Granoff; R Rockwell
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

5.  The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b.

Authors:  H Käyhty; H Peltola; V Karanko; P H Mäkelä
Journal:  J Infect Dis       Date:  1983-06       Impact factor: 5.226

6.  The isolation of IgG from mammalian sera with the aid of caprylic acid.

Authors:  M Steinbuch; R Audran
Journal:  Arch Biochem Biophys       Date:  1969-11       Impact factor: 4.013

7.  The paradox of Hemophilus infuenzae type B bacteremia in the presence of serum bactericidal activity.

Authors:  S Shaw; A L Smith; P Anderson; D H Smith
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

8.  Assessment of Haemophilus influenzae type b opsonins by neutrophil chemiluminescence.

Authors:  S L Kaplan; C L Umstead; E O Mason; D C Anderson; J C Parke; R D Feigin
Journal:  J Clin Microbiol       Date:  1981-03       Impact factor: 5.948

9.  Immunization of humans with polyribophosphate, the capsular antigen of Hemophilus influenzae, type b.

Authors:  P Anderson; G Peter; R B Johnston; L H Wetterlow; D H Smith
Journal:  J Clin Invest       Date:  1972-01       Impact factor: 14.808

10.  The intrinsic affinity constant (K) of anticapsular antibody to oligosaccharides of Haemophilus influenzae type b.

Authors:  S V Hetherington
Journal:  J Immunol       Date:  1988-06-01       Impact factor: 5.422

View more
  3 in total

1.  Outer membrane protein binding sites of complement component 3 during opsonization of Haemophilus influenzae.

Authors:  S V Hetherington; C C Patrick; E J Hansen
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

2.  Complement component 3 binding to Haemophilus influenzae type b in the presence of anticapsular and anti-outer membrane antibodies.

Authors:  S V Hetherington; C C Patrick
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

3.  Complement activation by polyclonal immunoglobulin G1 and G2 antibodies against Staphylococcus aureus, Haemophilus influenzae type b, and tetanus toxoid.

Authors:  R G Bredius; P C Driedijk; M F Schouten; R S Weening; T A Out
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.